<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02920034</url>
  </required_header>
  <id_info>
    <org_study_id>Radiosound 1.1</org_study_id>
    <nct_id>NCT02920034</nct_id>
  </id_info>
  <brief_title>Randomized Comparison of Ultrasound Versus Radiofrequency Denervation in Patients With Therapy Resistant Hypertension</brief_title>
  <acronym>RADIOSOUND</acronym>
  <official_title>A Randomized Comparison of Ultrasound Based Versus Radiofrequency Based Catheter Ablation Techniques in Patients With Therapy Resistant Arterial Hypertension With Large Renal Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized trial to assess the effectiveness of different renal sympathetic
      denervation methods (radiofrequency main vs. branches + main vs. ultrasound based) in a
      cohort of patients with therapy refractory arterial hypertension and large renal arteries
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this trial is a prospective, randomized comparison of three different techniques
      for catheter based renal sympathetic denervation. Patients with larger (&gt;5.5 mm) renal
      arteries are randomized to a treatment with a radiofrequency based catheter of the main renal
      artery, the main renal artery, its side-branches and accessories or an ultrasound-based
      denervation of the main renal artery only. The primary endpoint is the change in daytime
      blood pressure acquired in ambulatory blood pressure measurement at 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Daytime blood pressure change</measure>
    <time_frame>3 months after Intervention</time_frame>
    <description>Daytime blood pressure change in ambulatory blood pressure measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>General blood pressure change</measure>
    <time_frame>3 months after Intervention</time_frame>
    <description>Change in 24 h average blood pressure change in ambulatory blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daytime blood pressure change</measure>
    <time_frame>6 months after Intervention</time_frame>
    <description>Daytime blood pressure change in ambulatory blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General blood pressure change</measure>
    <time_frame>6 months after Intervention</time_frame>
    <description>Change in 24 h average blood pressure change in ambulatory blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daytime blood pressure change</measure>
    <time_frame>12 months after Intervention</time_frame>
    <description>Daytime blood pressure change in ambulatory blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General blood pressure change</measure>
    <time_frame>12 months after Intervention</time_frame>
    <description>Change in 24 h average blood pressure change in ambulatory blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise blood pressure change</measure>
    <time_frame>3 months after Intervention</time_frame>
    <description>Change in exercise blood pressure on bicycle stress testing</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Therapy Resistant Hypertension</condition>
  <arm_group>
    <arm_group_label>Radiofrequency main renal artery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Renal sympathetic denervation of the main renal artery using the radiofrequency-based Spyral™ catheter (Medtronic, MN, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofrequency main and branches</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal sympathetic denervation of the main renal artery, its branches and accessories using the radiofrequency-based Spyral™ catheter (Medtronic, MN, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound main renal artery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal sympathetic denervation of the main renal artery using the ultrasound-based Paradise™ catheter (ReCor, CA, USA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiofrequency denervation of the main renal arteries</intervention_name>
    <description>Catheter based renal sympathetic denervation of the main renal arteries using the Spyral™ Catheter (Medtronic, MN, USA)</description>
    <arm_group_label>Radiofrequency main renal artery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Radiofrequency denervation of renal arteries and branches</intervention_name>
    <description>Catheter based renal sympathetic denervation of the main renal arteries and its branches using the Spyral™ Catheter (Medtronic, MN, USA)</description>
    <arm_group_label>Radiofrequency main and branches</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound denervation of the main renal arteries</intervention_name>
    <description>Catheter based renal sympathetic denervation of the main renal arteries using the Paradise™ Catheter (ReCor Medical, CA, USA)</description>
    <arm_group_label>Ultrasound main renal artery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with resistant hypertension (≥3 antihypertensive drugs including at least one
             diuretic, without any dosage change in the preceding 4 weeks) and a systolic office
             blood pressure of &gt;160 mmHg, ≥1 main renal artery diameter &gt;5.5 mm

        Exclusion Criteria:

          -  pregnancy, known renal artery stenosis, average systolic daytime RR &lt;135 mmHg in 24h
             ambulatory blood pressure measurement (ABPM), ≥1 renal artery diameter &lt;4.0 mm,
             life-expectancy &lt;6 months, participation in any other clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp C Lurz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center of the University Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philipp C Lurz, MD, PhD</last_name>
    <phone>0049341865252022</phone>
    <email>Philipp.Lurz@gmx.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karl Fengler, MD</last_name>
    <phone>0049341865251197</phone>
    <email>Karl.Fengler@web.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>+49341865252022</phone>
      <email>Philipp.Lurz@gmx.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2016</study_first_submitted>
  <study_first_submitted_qc>September 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2016</study_first_posted>
  <last_update_submitted>October 29, 2017</last_update_submitted>
  <last_update_submitted_qc>October 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>PD Dr. Dr. med. Philipp Lurz</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

